Elevated plasma fibrinogen levels as an independent prognostic marker in breast cancer patients

被引：0
|
作者：
Krenn-Pilko, S. [1 ]
Langsenlehner, U. [2 ]
Thurner, E. -M [1 ]
Stojakovic, T. [3 ]
Pichler, M. [4 ]
Gerger, A. [5 ]
Kapp, K. S. [1 ]
Langsenlehner, T. [1 ]
机构：
[1] Med Univ Graz, Univ Klin Strahlentherapie & Radioonkol, Graz, Austria
[2] Steiermark Gebietskankenkasse, Graz, Austria
[3] Med Univ Graz, Klin Inst Med & Chem Labordiagnost, Graz, Austria
[4] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA
[5] Med Univ Graz, Klin Abt Onkol, Graz, Austria
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2014年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [31] Prognostic Significance of Pretreatment Plasma Fibrinogen and Platelet Levels in Patients with Early-Stage Cervical Cancer
    Zhao, Kelei
    Deng, Huan
    Qin, Yan
    Liao, Wenjun
    Liang, Weijiang
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2015, 79 (01) : 25 - 33
  • [32] MDM2 as an independent prognostic marker in breast carcinoma patients
    Turbin, DA
    Cheang, MCU
    Gelmon, K
    Yorida, E
    Nielson, TO
    Gilks, CB
    Huntsman, DG
    MODERN PATHOLOGY, 2005, 18 : 53A - 53A
  • [33] Elevated plasma fibrinogen levels in patients with essential hypertension are related to vascular complications
    Lechi, C
    Gaino, S
    Zuliani, V
    Tommasoli, RM
    Faccini, G
    Fasson, R
    Arcaro, G
    Lechi, A
    Minuz, P
    INTERNATIONAL ANGIOLOGY, 2003, 22 (01) : 72 - 78
  • [34] MDM2 as an independent prognostic marker in breast carcinoma patients
    Turbin, DA
    Cheang, MCU
    Gelmon, K
    Yorida, E
    Nielsen, TO
    Gilks, CB
    Huntsman, DG
    LABORATORY INVESTIGATION, 2005, 85 : 53A - 53A
  • [35] Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer: Aretrospective analysis
    Asamer, Eva
    Szkandera, Joanna
    Gibiser, Paul
    Lembeck, Anna Lena
    Stojakovic, Tatjana
    Kornprat, Peter
    Lackner, Caroline
    Winder, Thomas
    Schlick, Konstantin
    Stoeger, Herbert
    Gerger, Armin
    Pichler, Martin
    Stotz, Michael
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 (19-20) : 569 - 574
  • [36] ELEVATED LEVELS OF PRO-CATHEPSIN-D IN THE PLASMA OF BREAST-CANCER PATIENTS
    JAROSZ, DE
    HAMER, PJ
    TENNEY, DY
    ZABRECKY, JR
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (04) : 859 - 865
  • [37] PLASMA LEVELS OF HEPARANASE AS A MARKER OF TUMOR PROGRESSION AND AGGRESSIVENESS IN PATIENTS WITH COLORECTAL AND BREAST CANCER
    Kuten, J.
    Haim, N.
    Epelbaum, R.
    Fried, G.
    Ben Itzhak, O.
    Danus, S.
    Shaft, I.
    Vlodavsky, I.
    ANNALS OF ONCOLOGY, 2010, 21 : 76 - 76
  • [38] Prognostic significance of elevated plasma big endothelin-1 levels in patients with colorectal cancer
    Arun, C
    Elahi, M
    London, NJM
    Hemingway, DM
    BRITISH JOURNAL OF SURGERY, 2002, 89 : 12 - 12
  • [39] Plasma Apolipoprotein A1 Levels at Diagnosis Are Independent Prognostic Factors in Invasive Ductal Breast Cancer
    Lin, Xiaorong
    Hong, Shubin
    Huang, Jiefeng
    Chen, Yi
    Chen, Yufeng
    Wu, Zhiyong
    DISCOVERY MEDICINE, 2017, 23 (127) : 247 - 258
  • [40] KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients
    Kammerer, Sarah
    Sokolowski, Armin
    Hackl, Hubert
    Platzer, Dieter
    Jahn, Stephan Wenzel
    El-Heliebi, Amin
    Schwarzenbacher, Daniela
    Stiegelbauer, Verena
    Pichler, Martin
    Rezania, Simin
    Fiegl, Heidelinde
    Peintinger, Florentia
    Regitnig, Peter
    Hoefler, Gerald
    Schreibmayer, Wolfgang
    Bauernhofer, Thomas
    ONCOTARGET, 2016, 7 (51): : 84705 - 84717
12345